Valuation: MindMaze Therapeutics Holding SA

Market Cap 25.23M 30.64M 26.72M 22.91M 42.92M 2.94B 43.1M 302M 117M 1.49B 115M 113M 4.81B P/E 2026 *
-3.71x
P/E 2027 * 1.06x
Enterprise Value 16.81M 20.41M 17.8M 15.26M 28.6M 1.96B 28.72M 201M 77.69M 996M 76.68M 74.98M 3.2B EV / Sales 2026 *
2.85x
EV / Sales 2027 * 0.14x
Free-Float
36.59%
Yield 2026 *
-
Yield 2027 * -
1 day-7.94%
1 week-11.67%
Current month-18.55%
1 month-27.61%
3 months-35.90%
6 months-69.40%
Current year-92.19%
1 week 0.15
Extreme 0.1482
0.18
1 month 0.15
Extreme 0.1482
0.22
Current year 0.15
Extreme 0.1482
1.87
1 year 0.15
Extreme 0.1482
2.92
3 years 0.15
Extreme 0.1482
2.92
5 years 0.15
Extreme 0.1482
2.92
10 years 0.15
Extreme 0.1482
2.92
Date Insider Type Main position Quantity % Market Cap. Importance
19/12/25 Sell 140,000 0.0908%
19/12/25 Sell 52,162 0.0338%
19/12/25 Sell 281,968 0.1830%
Change 5-day change 1-year change 3-year change Capi.($)
-7.94%-11.67% - - 30.64M
+0.11%+2.71%+0.33%+28.59% 46.28B
-1.12%+1.78%+40.07%+27.26% 43.85B
-3.04%-6.29%+322.27%+517.36% 40.93B
-0.74%+1.25%+2.32%+67.94% 39.9B
-0.50%+0.67%+11.79%+40.51% 29.5B
-0.46%+4.22%+21.99%+124.21% 17.09B
-0.97%-10.17% - - 15.55B
-0.57%+8.12%+22.15%+38.93% 15.22B
-3.14%+31.91%-10.60% - 14.05B
Average -1.69%+2.22%+51.29%+120.69% 26.24B
Weighted average by Cap. -1.02%+1.87%+64.69%+130.23%

Financials

2026 *2027 *
Net sales 5.9M 7.17M 6.25M 5.36M 10.04M 688M 10.08M 70.67M 27.27M 350M 26.92M 26.32M 1.12B 43.2M 52.47M 45.75M 39.23M 73.5M 5.03B 73.81M 517M 200M 2.56B 197M 193M 8.24B
Net income -7.81M -9.49M -8.27M -7.09M -13.29M -910M -13.34M -93.56M -36.11M -463M -35.64M -34.85M -1.49B 24.83M 30.15M 26.29M 22.54M 42.24M 2.89B 42.42M 297M 115M 1.47B 113M 111M 4.73B
Net Debt -8.42M -10.23M -8.92M -7.65M -14.32M -981M -14.38M -101M -38.92M -499M -38.41M -37.56M -1.61B -19.27M -23.4M -20.41M -17.5M -32.78M -2.25B -32.92M -231M -89.07M -1.14B -87.91M -85.96M -3.67B
Logo MindMaze Therapeutics Holding SA
MindMaze Therapeutics Holding SA, formerly known as RELIEF THERAPEUTICS Holding SA, is a Switzerland-based company that engages in research, development, production, and sale of biotechnology, pharmaceutical, diagnostic, therapeutic, chemical, and cosmetic products. The Company acquires and manages patents, licenses, and intellectual property, provides preclinical, clinical, and regulatory services, and may establish subsidiaries worldwide. The Company also participates in the acquisition, holding, and financing of interests in companies, offers management services to affiliates, and develops scientific and economic solutions for disease treatment and therapeutic approaches. Additionally, the Company may acquire, hold, and sell trademarks and other IP rights globally, and provide or obtain financing through loans or guarantees to support its corporate purpose.
Employees
-
Date Price Change Volume
18/09/26 CHF 0.1484 -7.94% 3,415,161
17/09/26 CHF 0.1612 +4.54% 2,115,258
16/09/26 CHF 0.1542 -3.50% 1,174,395
15/09/26 CHF 0.1598 -1.96% 778,521
14/09/26 CHF 0.1630 -2.98% 887,025
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
CCC

Annual profits - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!